LB
GILD icon

Landmark Bank’s Gilead Sciences GILD Stock Holding History

Landmark Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.92M Sell
44,923
-2,687
-6% -$175K 0.66% 22
2019
Q3 		$3.02M Buy
47,610
+127
+0.3% +$8.3K 1.94% 21
2019
Q2 		$3.21M Buy
47,483
+693
+1% +$45.6K 2.11% 17
2019
Q1 		$3.04M Buy
46,790
+7,039
+18% +$468K 2.09% 17
2018
Q4 		$2.49M Buy
39,751
+8,101
+26% +$566K 1.84% 23
2018
Q3 		$2.44M Buy
31,650
+6
+0% +$453 1.5% 26
2018
Q2 		$2.24M Buy
+31,644
New +$2.23M 1.45% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Landmark Bank's GILD Position: Q4 2019 in Review

Landmark Bank reduced its Gilead Sciences (GILD) stake by 5.6% in Q4 2019, selling an estimated $175K and leaving 44,923 shares worth $2.92M. The position accounts for 0.66% of the portfolio, ranked #22.

Landmark Bank first reported a position in GILD in Q2 2018 and has held it in 7 quarters since. The position peaked at $3.21M in Q2 2019. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Landmark Bank held 44,923 shares of Gilead Sciences worth $2.92M as of Q4 2019.
  • Landmark Bank sold 2,687 Gilead Sciences shares in Q4 2019, an estimated $175K.
  • Gilead Sciences made up 0.66% of Landmark Bank's portfolio in Q4 2019, its #22 holding.
  • Landmark Bank first reported a position in Gilead Sciences in Q2 2018 and has held it in 7 quarters since.
  • Landmark Bank's Gilead Sciences position peaked at $3.21M in Q2 2019.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Landmark Bank's 13F filing for Q4 2019, filed 12 Feb 2020.